Skip to content
Skip to navigation menu

 

Prof Philip Routledge  -  OBE


Qualifications

Professor Philip A Routledge graduated with a Bachelor’s degree in medicine and Surgery (MB BS) in 1972 from the University of Newcastle where later obtained his MD (with commendation, in 1978). He obtained Membership of the Royal College of Physicians (MRCP [UK]) in 1975, and was elected Fellow of the Royal Colleges of Physicians of London (FRCP 1986), and of Edinburgh (FRCPE 2002) and of the British Toxicological Society (FBTS 2006).

He was appointed Officer of the Order of the British Empire (OBE) in the 2008 New Year's Honours List

 

Career Profile

Phil Routledge joined the staff of the Department of Pharmacology in Newcastle University in 1975 as a research registrar. In 1977 he was awarded a Merck, Sharp and Dohme International Fellowship in Clinical Pharmacology and gained experience in Vanderbilt and Duke Universities, before being appointed Assistant Professor of Medicine (Medical Research) at Duke University in 1979. In 1980, he returned to the UK as Lecturer in Clinical Pharmacology in the University of Newcastle upon Tyne, before joining the University of Wales College of Medicine (now Cardiff University School of Medicine) as Senior lecturer (1981). Reader (1986) and Professor (1989) of Clinical Pharmacology.

 

Scientific service

Professor Routledge has contributed to the work of a number of national bodies. He has been a member of the MHRA’s regulatory bodies, including the Sub Committee on Efficacy and Adverse Reactions (SEAR) and the Adverse Reactions Group of SEAR (ARGOS), the MHRA External Advisory Panel, the sub-committee on Pharmacovigilance and finally the UK Medicines Commission (2002-2005). In 2005, he was appointed the first chairman of the newly-formed UK Herbal Medicines Advisory Committee.

He has served on the UK Government Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment  (1998-2000) and the Appraisal Committee of the National Institute of Health and Clinical Excellence (1999-2006). In 2006, he was appointed Chairman of the All-Wales Medicines Strategy Group, which advises Welsh Assembly Government, particularly in relation to the introduction of new medicines in Wales.

 

Professional service

In pharmacology and medical education, Professor Routledge has served as the Royal College of Physicians of London’s (RCP) Tutor (and Acting Postgraduate Organiser) at Llandough Hospital RCP Regional Adviser (South Wales), RCP Continuing Medical Education Advisor (South Wales) and as a member of the RCP Education Committee.

He has been a Member of the Clinical Section Committee of the British Pharmacological Society (BPS), Assistant Editor of the Society’s clinical journal, the British Journal of Clinical Pharmacology and Honorary Secretary of the Clinical Section of the BPS. He is presently a member of the Council of the BPS. Since 1995, he has chaired the All Wales Higher Specialist Training Committee on Clinical Pharmacology and Therapeutics.

Phil Routledge has been external examiner/ adviser on 12 undergraduate programmes in medicine or pharmacology and 2 postgraduate courses in the UK and Ireland. He is Course Director of Cardiff University’s postgraduate Diploma/MSc in Therapeutics, Certificate/ Diploma/MSC in Medical Toxicology and Diplomas/MSc in Occupational Health programmes. He is a member of the Academy of Medical Educators.

 

Clinical Service

Since 1981, Professor Routledge has been an honorary consultant general physician with acute medical intake responsibilities at Llandough Hospital, Cardiff. From 1984 until 2005, He was Director of the Welsh National Poisons Unit, now the National Poisons Information Service (Cardiff Centre). Since 1986, he has been Consultant Advisor in Toxicology to the Chief Medical Officer (Wales). For 7 years, he served as a Non-Executive Director on Llandough Hospital and Community NHS Trust Board and is now Clinical Director of Therapeutics, Toxicology and Occupational Health in Cardiff and Vale NHS Trust

Throughout his career, Phil Routledge has collaborated closely with colleagues in the pharmacy profession to help to develop new clinical services, including the Northern Regional Drug and Poisons Information Service (1976), the Welsh Adverse Drug Reactions Scheme, now the Yellow Card Centre Wales (1983) and most recently, the Welsh Medicines Partnership (2002), where he is Medical Director.

Professor Routledge also helped to establish, and for several years, was Associate Director of the Chemical Incident Management Support Unit for Wales (199-2000) and the UK National Focus for Chemical Incidents (1996-2000). He continues as Associate Director of the World Health Organisation’s Clearing House for Chemical Incidents.